Medtronic Initiates PRODIGY – a Global Study to Identify Those at High Risk for Opioid Induced Respiratory Depression, a Preventable Form of Respiratory Compromise

Medtronic announced last week the initiation of the PRODIGY study, a prospective, multi-center, post-market, global study to Identify individuals at high risk for opioid induced respiratory depression (OIRD), a form of respiratory compromise.

PRODIGY is an important study as it is the first to assess the clinical and economic benefits of using pulse oximetry and capnography in patients receiving opioid medication on hospital general care floors. Findings from the study will potentially help clinicians determine strategies for earlier detection and prevention of OIRD.